APRICUS BIOSCIENCES, INC. AMENDMENT TOPurchase Common Stock • March 23rd, 2018 • Sarissa Capital Management LP • Pharmaceutical preparations • New York
Contract Type FiledMarch 23rd, 2018 Company Industry JurisdictionThis Amendment to Warrant to Purchase Common Stock (this “Amendment”), dated as of March 21, 2018 (the “Effective Date”), is being entered into by and between Apricus Biosciences, Inc., a Nevada corporation (the “Company”) and Sarissa Capital Offshore Master Fund LP, a Cayman Islands exempted limited partnership (the “Holder”).